Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Midodrine Hydrochloride in Early Sepsis: Randomized, Double Blind and Placebo-Controlled Feasibility Study

NCT03129542 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03129542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03129542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Midodrine Hydrochloride in Early Sepsis: Randomized, Double Blind and Placebo-Controlled Feasibility Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
August 30, 2017
Completion date
May 15, 2020
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, sepsis